Chapter 3 – Treatment of transplant-eligible patients

Contributors: Mohamad Mohty, Florent Malard, Jean-Luc Harousseau

Multiple Choice Questionnaire

Which HDT regimen demonstrates the best efficacy/toxicity ratio prior to autologous transplantation?
The use of lenalidomide as maintenance therapy has the potential risk of increasing the incidence of which of the below?
When is allogeneic transplantation recommended as treatment for multiple myeloma?
Multiple Choice Questionnaire: Chapter 3 - Treatment of transplant-eligible patients
You got {{userScore}} out of {{maxScore}} correct
{{title}}
{{image}}
{{content}}